ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lexapro For Teen Anxiety & Depression: Side Effects & Safety Guide Released

Mental health treatment center Mission Prep has released an expert guide to Lexapro (escitalopram) as a treatment option for teens suffering from depression or anxiety.

-- With antidepressants now being among the front-line treatments for teen depression, California-based Mission Prep has published a new guide focusing on Lexapro (escitalopram). The guide was developed with both parents and teens in mind, and addresses some of the most common questions and concerns.

More details can be found at https://missionprephealthcare.com/mental-health-resources/antidepressants/lexapro/

Mission Prep specializes in residential mental health treatment programs for teens, with centers in California and Virginia. As such, the organization has extensive experience with the use of antidepressants for mental health struggles, which it wants to share via its growing online resource library.

According to the CDC’s Youth Risk Behavior Survey, nearly 1 in 3 high school students reported poor mental health in 2021, and around 15% said they had been prescribed antidepressants. Escitalopram for teenagers, often sold under the brand name Lexapro, is one of the more frequently prescribed SSRIs.

As Mission Prep points out, receiving a prescription for antidepressants can often feel overwhelming for both teens and their parents. Understanding what the medication is, how it works, and the potential side effects can reduce discontinuation rates, thereby improving long-term outcomes.

“Teens and their families deserve straightforward information about treatment options, especially when those options involve long-term medication,” a Mission Prep representative explains. “That’s why we created this guide—to answer common questions in a calm and honest way.”

About Mission Prep

Offering focused residential and outpatient programs developed specifically for adolescents, Mission Prep is a state-licensed facility that aims to provide meaningful and effective support. The center uses proven techniques, such as recovery-oriented cognitive therapy (CT-R) and cognitive behavioral therapy (CBT) to address a range of mental health struggles, including depression, anxiety, bipolar disorder, mood and thought disorder, trauma and PTSD, and more.

“Mission Prep aims to provide support and sustainable change for adolescents and families who are challenged by teen mental health issues through our adolescent mental health programs,” the company continued. “To do this, we utilize a blend of time-tested therapeutic approaches as well as innovative interventions, preparing teens for the challenges of life and giving families the fresh start they need.”

Interested parties can find more information by visiting https://missionprephealthcare.com/

Contact Info:
Name: Nathan Di Tomaso
Email: Send Email
Organization: Mission Prep
Address: 30310 Rancho Viejo Rd., San Juan Capistrano, California 92675, United States
Website: https://missionprephealthcare.com/

Source: PressCable

Release ID: 89164081

In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.